| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/21/2004 | EP1409467A1 Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors |
| 04/21/2004 | EP1409466A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 04/21/2004 | EP1409463A1 N-heterocyclic inhibitors of tnf-alpha expression |
| 04/21/2004 | EP1409461A1 Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides |
| 04/21/2004 | EP1409452A1 Sulfonamide derivatives |
| 04/21/2004 | EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 04/21/2004 | EP1409446A1 Method for the nitration of phenolic compounds |
| 04/21/2004 | EP1409018A2 Stable lyophilized pharmaceutical formulation of igg antibodies |
| 04/21/2004 | EP1409007A2 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 04/21/2004 | EP1409005A1 Modulators of notch signalling for use in immunotherapy |
| 04/21/2004 | EP1408995A1 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 04/21/2004 | EP1408983A2 Method of treating hyperproliferative diseases using active vitamin d analogues |
| 04/21/2004 | EP1408982A1 Pharmaceutical compositions for treatment of digestive disorders and associated diseases |
| 04/21/2004 | EP1408977A1 A combination therapy for the treatment of heart failure |
| 04/21/2004 | EP1408976A1 Treatment for attention-deficit hyperactivity disorder |
| 04/21/2004 | EP1408970A1 Indolines and tetrahydro-quinolines as prodrugs for tumour treatment |
| 04/21/2004 | EP1408965A2 Use of dual h3/m2 antagonists with a bipiperidinic structure in the treatment of cognition deficit disorders |
| 04/21/2004 | EP1408964A2 Novel use of 2- 5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts |
| 04/21/2004 | EP1408952A1 Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
| 04/21/2004 | EP1408951A2 Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers |
| 04/21/2004 | EP1408942A1 Methods and clinical devices for the inhibition or prevention of mammalian cell growth |
| 04/21/2004 | EP1408939A1 Methods for preparation and use of 1 alpha,24(s)-dihydroxyvitamin d2 |
| 04/21/2004 | EP1408937A2 Use of antagonists or partial agonists of 5ht1a receptors for the preparation of a medicament for treatment and prevention of gastrointestinal diseases |
| 04/21/2004 | EP1408936A2 Pharmaceutical composition |
| 04/21/2004 | EP1408931A1 Modifying the fatty acid composition of cell membranes of organs and tissues |
| 04/21/2004 | EP1408908A2 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 04/21/2004 | EP1287355B1 Methods and compounds for influencing beta3 integrin-dependent intracellular processes |
| 04/21/2004 | EP1242389B1 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 04/21/2004 | EP1228039B1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 04/21/2004 | EP1149094B1 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors |
| 04/21/2004 | EP1149079B1 Tetrahydro isoquino linealkanol derivatives and pharmaceutical compositions containing same |
| 04/21/2004 | EP1112074B1 Taurolidine and/or taurultam against infectious ulcer or gastritis |
| 04/21/2004 | EP1105370B1 Novel aryl sulphonamides and analogues |
| 04/21/2004 | EP1071701A4 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof |
| 04/21/2004 | EP1049699B1 Pyrazolotriazines as crf antagonists |
| 04/21/2004 | EP1049671B1 Azetidinecarboxamide derivatives for the treatment of cns disorders |
| 04/21/2004 | EP1039916B8 Use of at least one fucane for the manufacture of a medicament for the treatment of periodontal pathologies |
| 04/21/2004 | EP1018341B1 Antistress agents and functional foods |
| 04/21/2004 | EP0989858B1 Cd28/ctla-4 inhibiting peptidomimetics and pharmaceutical compositions thereof |
| 04/21/2004 | EP0964860B1 Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions |
| 04/21/2004 | EP0856007B1 Cyclopeptide derivatives |
| 04/21/2004 | EP0683781B1 Novel inhibitors of adenosine monophosphate deaminase |
| 04/21/2004 | CN1491232A Modified leptin with reduced immunogenicity |
| 04/21/2004 | CN1491231A Modified keratinocyte growth factor (KGF) with reduced immunogenicity |
| 04/21/2004 | CN1491227A Triazoloquinazoline and pyrazolotriazolopyrimidine derivatives, medicinal compositions, adenosine A3 receptor affinity agents, ocular tension lowering agents, preparations for preventing and treating |
| 04/21/2004 | CN1491225A Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient |
| 04/21/2004 | CN1491222A Piperidinee derivatives as neurokinin/antagonists |
| 04/21/2004 | CN1491221A Thiophene substituted amine derivatives as GLYT-1 inhibitors |
| 04/21/2004 | CN1491220A Lactone compound as novel photoinitiators |
| 04/21/2004 | CN1491213A Novel benzoylguanidine salt |
| 04/21/2004 | CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 04/21/2004 | CN1491207A Acylated indanyl amines and their use as pharmaceuticals |
| 04/21/2004 | CN1491197A Tropolone derivative |
| 04/21/2004 | CN1491191A Method and device for manufacturing advanced water containing ultra-fine gold particles |
| 04/21/2004 | CN1491089A Composition and method for smoke detoxification |
| 04/21/2004 | CN1490049A CD26/DPP IV application for medicine in preparing treatment and/or diagnostic disease |
| 04/21/2004 | CN1490047A Chinese medicine composition for travelling health-protection and preparing method thereof |
| 04/21/2004 | CN1490036A Chemical for promoting growth of hairs and preventnig sinility |
| 04/21/2004 | CN1146575C Peptidyl heterocycles useful in the treatment of thrombin related disorders |
| 04/21/2004 | CN1146568C Novel cyano-indole thrombotonin reuptaking inhibitor compound, its preparation process and medicinal compositions having the same |
| 04/21/2004 | CN1146562C Thtraphydrothiopy 2,3-diazanaphthylaone derivatives as PDE4 inhibitors |
| 04/21/2004 | CN1146559C Muscarinic antagonists |
| 04/21/2004 | CN1146556C 1,2-dihydroindene or indoline derivatives, preparation and use thereof |
| 04/21/2004 | CN1146551C Substituted diazacycloheptane compound, medicine composition contg, same and the use thereof |
| 04/21/2004 | CN1146545C Benzoylpyridazines |
| 04/21/2004 | CN1146544C Pyrazoelcarboxylic acid derivatives, their preparation, pharmaceutical compositions containing |
| 04/21/2004 | CN1146543C Serine protease inhibitor |
| 04/21/2004 | CN1146541C Beta-alanine derivatives |
| 04/21/2004 | CN1146455C 1,2,4,5-tetrahydro-benzo[d] azepine compound |
| 04/21/2004 | CN1146440C Vascular endothelial growth factor-B |
| 04/21/2004 | CN1146434C Growth promoter for Children |
| 04/21/2004 | CN1146428C Crystallized pirimiphos-methyl composite and its preparation and usage |
| 04/21/2004 | CN1146418C Fixed-dose association of angiotensin-converting enzyme inhibitor and of calcium channel antagonist, method for preparation and use thereof in treatment of cardivas cular illnesses |
| 04/21/2004 | CN1146411C Use of 1,3-propanediol derivatives |
| 04/20/2004 | US6723751 Individual polymorphic forms of crystalline sodium salt having specified x-ray diffraction spectra |
| 04/20/2004 | US6723749 Treating bacterial infections |
| 04/20/2004 | US6723740 Administering therapeutic amount of human peroxisome proliferator activated receptor delta agonist to lower triglycerides |
| 04/20/2004 | US6723739 Glucopyranoside benzothiophenes |
| 04/20/2004 | US6723736 For therapy inflammation, inflammatory diseases, immunologic diseases and other diseases mediated by tumor necrosis factor-alpha (tnf-alpha) and/or interleukin 6 or 10 and/or enzyme cyclooxygenase-2 (cox-2) |
| 04/20/2004 | US6723730 Capsaicin receptor ligands |
| 04/20/2004 | US6723726 Protein tyrosine kinase inhibitors |
| 04/20/2004 | US6723725 Indole derivatives |
| 04/20/2004 | US6723724 Isoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptor, and preparation thereof |
| 04/20/2004 | US6723721 CRF receptor antagonists and methods relating thereto |
| 04/20/2004 | US6723719 Dysmenorrhoea, benign prostatic hyperplasia (bph), bladder outlet obstruction, incontinence, agina, congestive heart failure, atherosclerosis; hypotensive and antiallergen agents |
| 04/20/2004 | US6723718 Substituted α, β-anellated butyrolactones |
| 04/20/2004 | US6723708 Lithium chloride |
| 04/20/2004 | US6723703 Administering powder or aerosol to nasal mucosa and osteomeatal complex |
| 04/20/2004 | US6723696 Drug screening for agents to treat hypercalcemia and osteoporosis |
| 04/20/2004 | US6723695 Cytotoxic epstein-barr virus (ebv) t-cell epitopes derived from ebv structural antigens; vaccines |
| 04/20/2004 | US6723552 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 04/20/2004 | US6723525 Methods and compositions for screening modulators of lipid kinases |
| 04/20/2004 | US6723522 For use as an antibody, in expression systems, for measuring activity of the cotransporter, in drug screening and design, or as a reagent for making a probe or a pcr primer, making transgenic animal |
| 04/20/2004 | US6723511 Suppression of apoptosis in cell; obtain cells, incubate with blocking agent, monitor apoptosis in cells |
| 04/20/2004 | US6723372 Spraying grains which consist of a prostane derivative and a cyclodextrin vehicle, forming together a prostane-cyclodextrine-clathrate, with an aqueous polymer dispersion of ethyl cellulose and/or poly(methyl)acrylic acid ester |
| 04/20/2004 | US6723350 Powder of one or more antimicrobial metals formed with atomic disorder; coating becomes antimicrobial and anti-inflammatory when wet. |
| 04/20/2004 | US6723348 Orodispersible tablets containing fexofenadine |
| 04/20/2004 | US6723335 Methods and compositions for treating intervertebral disc degeneration |
| 04/20/2004 | CA2310136C Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders |
| 04/20/2004 | CA2300382C New psoralens for pathogen inactivation |